These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6431692)

  • 1. Contributions to the optimal use of human blood. IX. Elimination of hepatitis B transmission by (potentially) infectious plasma derivatives.
    Stephan W
    Vox Sang; 1984; 46(6):421. PubMed ID: 6431692
    [No Abstract]   [Full Text] [Related]  

  • 2. [Obtaining protein fractions from human blood which are safe from the viewpoint of hepatitis transmission].
    Stephan W
    Vnitr Lek; 1980 Jan; 26(1):59-62. PubMed ID: 6766595
    [No Abstract]   [Full Text] [Related]  

  • 3. Inactivation of hepatitis B and non-A, non-B viruses by combined use of Tween 80, beta-propiolactone, and ultraviolet irradiation.
    Prince AM; Stephan W; Kotitschke R; Brotman B
    Thromb Haemost; 1983 Aug; 50(2):534-6. PubMed ID: 6415846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inactivation of hepatitis non-A, non-B virus in intravenous immunoglobulins by beta-propiolactone].
    Dichtelmüller H; Stephan W; Prince AM; Brotman B
    Beitr Infusionsther; 1988; 21():202-4. PubMed ID: 2462976
    [No Abstract]   [Full Text] [Related]  

  • 5. [Route of transmission and prevention of non-A, non-B hepatitis].
    Iino S
    Nihon Rinsho; 1988 Dec; 46(12):2729-34. PubMed ID: 3149346
    [No Abstract]   [Full Text] [Related]  

  • 6. [Selection of donors in the prevention of post-transfusion viral hepatitis].
    Massaro AL
    Riv Emoter Immunoematol; 1985; 32(2):156-9. PubMed ID: 3937210
    [No Abstract]   [Full Text] [Related]  

  • 7. Virus safety of beta-propiolactone treated plasma preparations. Clinical experiences.
    Heinrich D; Sugg U; Brackmann HH; Stephan W; Lissner R
    Dev Biol Stand; 1987; 67():311-7. PubMed ID: 3649316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Guidelines for working with blood in Stockholm County].
    Jordemodern; 1986 Jun; 99(6):216-7. PubMed ID: 3091547
    [No Abstract]   [Full Text] [Related]  

  • 9. Current status of posttransfusion hepatitis.
    Alter HJ; Holland PV; Purcell RH
    Pathobiol Annu; 1980; 10():135-56. PubMed ID: 6777742
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention of post-transfusional hepatitis].
    Hernández JM
    Sangre (Barc); 1988 Jun; 33(3):242. PubMed ID: 3140399
    [No Abstract]   [Full Text] [Related]  

  • 11. Revision of the protocol recommended for studies of safety from hepatitis of clotting factor concentrates. International Society for Thrombosis and Hemostasis.
    Mannucci PM; Colombo M
    Thromb Haemost; 1989 Jun; 61(3):532-4. PubMed ID: 2508261
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis C, other types of non-B parenteral hepatitis and blood transfusion.
    Dodd RY
    Dev Biol Stand; 1993; 81():35-40. PubMed ID: 8174817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing hepatitis by testing blood for alanine aminotransferase.
    Kahn RA
    N Engl J Med; 1983 Apr; 308(14):844-5. PubMed ID: 6403860
    [No Abstract]   [Full Text] [Related]  

  • 14. Transfusion-transmitted hepatitis virus infection.
    Dodd RY
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):137-54. PubMed ID: 7737938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of hepatitis-B immunoglobulin to clotting factors.
    Smit Sibinga CT; Das PC; Nieweg HO
    Lancet; 1980 Sep; 2(8193):537. PubMed ID: 6105586
    [No Abstract]   [Full Text] [Related]  

  • 16. [Measurement of serum guanase activity and prevention of non-A, non-B hepatitis].
    Yamasaki S; Egashira S; Koga M; Akagawa H
    Nihon Rinsho; 1984 Mar; 42(3):740-53. PubMed ID: 6433080
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acute viral hepatitis].
    Etienne JP
    Rev Prat; 1990 Jun; 40(18):1629-30. PubMed ID: 2115199
    [No Abstract]   [Full Text] [Related]  

  • 18. [The role of the Ministry of Health in the prevention of diseases caused by blood transfusion].
    Wolpert Barraza E; Córdova MS; Robles Díaz G; Reyes López PA
    Gac Med Mex; 1994; 130(6):412-24. PubMed ID: 7557054
    [No Abstract]   [Full Text] [Related]  

  • 19. [Post-transfusion hepatitis. A pending issue].
    Sánchez-Quijano A; Pineda JA; Lissen E
    Med Clin (Barc); 1988 Jun; 91(3):117-8. PubMed ID: 3139945
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical conferences at the Johns Hopkins Hospital. Post-transfusion hepatitis.
    Johns Hopkins Med J; 1981 Jul; 149(1):45-9. PubMed ID: 6788994
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.